Lesson learned by COVID-19 outbreak: multilevel triage strategies in patients admitted to the emergency room in southern Italy

Submitted: 11 December 2020
Accepted: 9 February 2021
Published: 24 September 2021
Abstract Views: 1002
PDF: 415
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


After identifying a novel disease inducing a severe acute respiratory syndrome-related to coronavirus 2 (SARS-CoV-2) for epidemic pneumonia in China, the diffusion of infection is ongoing around the world, and Italy has been the second country in which an epidemic has been demonstrated. Clinical features of this infection may be summarized in viral pneumonia that SARS or acute respiratory distress syndrome (ARDS) may complicate. For this reason, this epidemic has been considerably more aggressive than the previous epidemic of SARS and Middle-East respiratory syndrome. Coronavirus disease 2019 (COVID-19) showed an easy diffusion from human to human and also showed to be more contagious than other viruses. So human contact should be avoided at the emergency room and for inpatients too. The Triage should be adapted to these new features in order to speed up procedures for the care of infected patients at high risk of morbidity and mortality for SARS and ARDS and for traditional access to the emergency room. Based on our experiences, this flow chart has been designed with a multi-level triage in which patients have been divided for admission to the emergency room into patients with fever/respiratory symptoms and patients without fever\respiratory symptoms, to improve medical performances while treating COVID-19. This organized, multilevel triage permitted a good selection of patients admitted to the emergency room during the epidemic of COVID-19 in Southern Italy.



PlumX Metrics


Download data is not yet available.


McCloskey B, Heymann DL. SARS to novel coronavirus: old lessons and new lessons. Epidemiol Infect 2020;148:e22. DOI: https://doi.org/10.1017/S0950268820000254
Giwa A, Desai A. Novel coronavirus COVID-19: an overview for emergency clinicians. Emerg Med Pract 2020;22:1-21.
Veronese N, Demurtas J, Yang L, et al. Use of corticosteroids in coronavirus disease 2019 pneumonia: a systematic review of the literature. Front Med [Epub ahead of print].
Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020;pii:S1473-3099(20)30086-4. DOI: https://doi.org/10.1016/S1473-3099(20)30086-4
Hui DS. Severe acute respiratory syndrome (SARS): lessons learnt in Hong Kong. J Thorac Dis 2013;5:S122-6.
Rebeaud M, Zores F. Chloroquine use as antiviral treatment and the new SARS CoV 2. Front Med 2020 [Epub ahead of print].
Yhmj Lim J, Jeon S, Shin HY, et al. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 2020;35:e79. DOI: https://doi.org/10.3346/jkms.2020.35.e89
Hillaker E, Belfer JJ, Bondici A, et al. Delayed initiation of remdesivir in a COVID-19 positive patient. Pharmacotherapy 2020 [In press]. DOI: https://doi.org/10.1002/phar.2403
Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease. Asian Pac J Allergy Immunol 2020;38:10-8.
Cellina M, Orsi M, Bombaci F, et al. Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab. Diagn Interv Imaging 2020;pii:S2211-5684(20)30087-5. DOI: https://doi.org/10.1016/j.diii.2020.03.010
Carannante N, Fiorentino G, Corcione A, et al. Administration of immunoglobulins in SARS-CoV-2-positive patient is associated with fast clinical and radiological healing: case report. Front Med (Lausanne) 2020;7:388. DOI: https://doi.org/10.3389/fmed.2020.00388
Rasmussen SA, Smulian JC, Lednicky JA, et al. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 2020 [In press]. DOI: https://doi.org/10.1097/01.aoa.0000719440.84472.52
De Lorenzo F, Buogo A, Soscia M, Schisa C. Identification and treatment with a long-acting sulphonamide of 15 carriers of Vibrio cholerae El Tor serotype Ogawa, during the 1973 cholera epidemic in Naples. Chemotherapy 1977;23:345-55. DOI: https://doi.org/10.1159/000222004
Zhang J, Zhou L, Yang Y, et al. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med 2020;8:e11-2. DOI: https://doi.org/10.1016/S2213-2600(20)30071-0
Lippi G, Mattiuzzi C, Sanchis-Gomar F, Henry BM. Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China. J Med Virol 2020 [Epub ahead of print]. DOI: https://doi.org/10.1002/jmv.25860
Grasselli G, Zangrillo A, Zanella A, et al.; COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020 [Epub ahead of print].
Ministero della Salute. PCM-DPC dati forniti dal Ministero della Salute; aggiornammento del 16/04/2020. Available from: http://www.salute.gov.it/imgs/C_17_notizie_4505_0_file.pdf
Interim Guidance. Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19); February 27, 2020. Geneva: World Health Organization. Available from: https://apps.who.int/iris/handle/10665/331215?show=full

How to Cite

Di Micco, P., Imparato, M., Iannuzzo, M. T., & Fontanella, A. (2021). Lesson learned by COVID-19 outbreak: multilevel triage strategies in patients admitted to the emergency room in southern Italy. Italian Journal of Medicine, 15(3). https://doi.org/10.4081/itjm.2021.1445